GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway

GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway

Background. GLP-1 receptor agonists (GLP-1RA) are common clinical agents that are clinically protective against diabetic complications, such as diabetic retinopathy (DR). Previous studies have shown that the RhoA/ROCK pathway plays an important role in the development of DR. However, the specific me...

Full description

Saved in:
Bibliographic Details
Main Authors: Liufeng Wei, Weiwei Mo, Shanshan Lan, Haiyan Yang, Zhenxing Huang, Xinghuan Liang, Li Li, Jing Xian, Xuemei Xie, Yingfen Qin, Faquan Lin, Zuojie Luo
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2022/1861940
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items